全文获取类型
收费全文 | 2262篇 |
免费 | 201篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 67篇 |
妇产科学 | 36篇 |
基础医学 | 231篇 |
口腔科学 | 29篇 |
临床医学 | 458篇 |
内科学 | 380篇 |
皮肤病学 | 53篇 |
神经病学 | 122篇 |
特种医学 | 117篇 |
外科学 | 364篇 |
综合类 | 73篇 |
预防医学 | 153篇 |
眼科学 | 39篇 |
药学 | 181篇 |
肿瘤学 | 156篇 |
出版年
2023年 | 20篇 |
2021年 | 57篇 |
2020年 | 33篇 |
2019年 | 44篇 |
2018年 | 48篇 |
2017年 | 41篇 |
2016年 | 36篇 |
2015年 | 41篇 |
2014年 | 72篇 |
2013年 | 101篇 |
2012年 | 127篇 |
2011年 | 105篇 |
2010年 | 100篇 |
2009年 | 100篇 |
2008年 | 114篇 |
2007年 | 118篇 |
2006年 | 89篇 |
2005年 | 121篇 |
2004年 | 99篇 |
2003年 | 101篇 |
2002年 | 73篇 |
2001年 | 61篇 |
2000年 | 59篇 |
1999年 | 57篇 |
1998年 | 36篇 |
1997年 | 39篇 |
1996年 | 37篇 |
1995年 | 35篇 |
1994年 | 29篇 |
1993年 | 25篇 |
1992年 | 40篇 |
1991年 | 37篇 |
1990年 | 24篇 |
1989年 | 35篇 |
1988年 | 24篇 |
1987年 | 23篇 |
1986年 | 14篇 |
1985年 | 19篇 |
1984年 | 10篇 |
1983年 | 23篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1980年 | 11篇 |
1979年 | 14篇 |
1978年 | 20篇 |
1977年 | 18篇 |
1976年 | 13篇 |
1974年 | 16篇 |
1972年 | 12篇 |
1966年 | 12篇 |
排序方式: 共有2479条查询结果,搜索用时 0 毫秒
81.
Cicuttini FM; Martin M; Salvaris E; Ashman L; Begley CG; Novotny J; Maher D; Boyd AW 《Blood》1992,80(1):102-112
We describe the development of a human bone marrow (BM) culture system which allows study of the interaction of stromal cell lines (SCL) and highly purified hematopoietic progenitor cells. Normal BM stromal cells were electroporated with a plasmid containing the simian virus 40 (SV40) large T antigen (SV40 T Ag) under the control of a synthetic metallothionein promoter (MT4); this construct is designated MT4 SV40 T Ag. SCL in which the rate of proliferation could be controlled by altering the zinc (Zn) concentration were characterized, demonstrating that the SCL were heterogeneous with respect to G-CSF and GM-CSF production. Suppression of SCL proliferation on removal of Zn made it possible to use these lines in coculture with purified CD34+ progenitor cells from umbilical cord blood. The ability to control proliferation of SCL has allowed us to maintain the survival and expansion of colony- forming cells in culture for up to 2 months. These lines have enabled us to test for stromal cell characteristics at a clonal level and provided us with a tool to analyze the events leading to lineage commitment and hematopoietic differentiation, as demonstrated by suppression of hematopoiesis by an antibody directed against the c-kit molecule. 相似文献
82.
83.
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation 总被引:16,自引:17,他引:16
Dunbar CE; Cottler-Fox M; O'Shaughnessy JA; Doren S; Carter C; Berenson R; Brown S; Moen RC; Greenblatt J; Stewart FM 《Blood》1995,85(11):3048-3057
We report here on a preliminary human autologous transplantation study of retroviral gene transfer to bone marrow (BM) and peripheral blood (PB)-derived CD34-enriched cells. Eleven patients with multiple myeloma or breast cancer had cyclophosphamide and filgrastim-mobilized PB cells CD34-enriched and transduced with a retroviral marking vector containing the neomycin resistance gene, and CD34-enriched BM cells transduced with a second marking vector also containing a neomycin resistance gene. After high-dose conditioning therapy, both transduced cell populations were reinfused and patients were followed over time for the presence of the marker gene and any adverse effects related to the gene-transfer procedure. All 10 evaluable patients had the marker gene detected at the time of engraftment, and 3 of 9 patients had persistence of the marker gene for greater than 18 months posttransplantation. The marker gene was detected in multiple lineages, including granulocytes, T cells, and B cells. The source of the marking was both the transduced PB graft and the BM graft, with a suggestion of better long-term marking originating from the PB graft. The steady- state levels of marking were low, with only 1:1000 to 1:10,000 cells positive. There was no toxicity noted, and patients did not develop detectable replication-competent helper virus at any time posttransplantation. These results suggest that mobilized PB cells may be preferable to BM for gene therapy applications and that progeny of mobilized peripheral blood cells can contribute long-term to engraftment of multiple lineages. 相似文献
84.
The contribution of von Willebrand factor (vWF)-platelet binding to platelet-collagen interaction was examined in vitro. The binding of vWF to platelets was mediated and regulated by ristocetin. Subthreshold concentrations of ristocetin (less than or equal to 1 mg/mL), insufficient to cause ristocetin-induced platelet aggregation (RIPA), were added to platelet-rich plasma (PRP) prior to the addition of collagen. The collagen-induced platelet aggregation (CIPA) was modified by ristocetin and the degree of alteration was dependent on the ristocetin concentration. Response as a function of ristocetin concentration was designated the Collagen-Platelet Aggregation Response (CoI-PAR). In normal PRP the CoI-PAR was a progressive inhibition followed by decreasing inhibition and then an enhanced response. The enhanced response occurred over a narrow range of ristocetin concentrations (0.8 to 1.0 mg/mL). In the absence of vWF (severe von Willebrand's disease, Type I, vWF less than 1%) the CoI-PAR was a progressive, eventually complete inhibition with no enhanced response (with ristocetin concentrations up to 3.0 mg/mL). With addition of vWF to this PRP an enhanced response was observed at a ristocetin concentration inversely proportional to the vWF level. PRP from a patient with severe Hemophilia A showed a response within the normal range. Subthreshold ristocetin did not cause plasma protein precipitation or platelet release of 3H-serotonin, nor induce micro platelet aggregate formation. Digestion of platelet membrane glycoproteins (GP(s] with chymotrypsin demonstrated that upon removal of GPI, RIPA was absent, CIPA retained and the CoI-PAR was progressive inhibition, with no enhancement. With removal of GPs I, II, and III, RIPA, CIPA, and the CoI-PAR were absent. A dose-response 125I-vWF- platelet binding occurred with increasing ristocetin concentrations which was unchanged by the addition of collagen. These results demonstrated that ristocetin-platelet association inhibited CIPA, and vWF-platelet binding enhanced platelet-collagen adhesion and platelet aggregation. The in vitro-enhanced CIPA represents a vWF-dependent aggregation of sufficient magnitude to overcome the inhibitory effect of ristocetin. These studies demonstrate an influential interaction of ristocetin, vWF, and collagen with the platelet membrane and imply an important hemostatic contribution of vWF-platelet binding in platelet- collagen interaction. 相似文献
85.
86.
Manoj K. Mittal MD Joel S. Tieder MD MPH Kathryn Westphal MD Erin Sullivan MPH Matt Hall PhD Risa Bochner MD Adam Cohen MD Jennifer Y. Colgan MD Atima C. Delaney MD Amy M. DeLaroche MBBS Thomas Graf MD Beth Harper MD Ron L. Kaplan MD Hannah C. Neubauer MD Mark I. Neuman MD MPH Nirav Shastri MD Victoria Wilkins MD MPH Allayne Stephans MD 《Academic emergency medicine》2023,30(6):662-670
87.
Benjamin K. Poulose Melina C. Vassiliou Brian J. Dunkin John D. Mellinger Robert D. Fanelli Jose M. Martinez Jeffrey W. Hazey Lelan F. Sillin Conor P. Delaney Vic Velanovich Gerald M. Fried James R. Korndorffer Jr. Jeffrey M. Marks 《Surgical endoscopy》2014,28(2):631-638
Background
Flexible endoscopy is an integral part of surgical care. Exposure to endoscopic procedures varies greatly in surgical training. The Society of American Gastrointestinal and Endoscopic Surgeons has developed the Fundamentals of Endoscopic Surgery (FES), which serves to teach and assess the fundamental knowledge and skills required to practice flexible endoscopy of the gastrointestinal tract. This report describes the validity evidence in the development of the FES cognitive examination.Methods
Core areas in the practice of gastrointestinal endoscopy were identified through facilitated expert focus groups to establish validity evidence for the test content. Test items then were developed based on the content areas. Prospective enrollment of participants at various levels of training and experience was used for beta testing. Two FES cognitive test versions then were developed based on beta testing data. The Angoff and contrasting group methods were used to determine the passing score. Validity evidence was established through correlation of experience level with examination score.Results
A total of 220 test items were developed in accordance with the defined test blueprint and formulated into two versions of 120 questions each. The versions were administered randomly to 363 participants. The correlation between test scores and training level was high (r = 0.69), with similar results noted for contrasting groups based on endoscopic rotation and endoscopic procedural experience. Items then were selected for two test forms of 75 items each, and a passing score was established.Conclusions
The FES cognitive examination is the first test with validity evidence to assess the basic knowledge needed to perform flexible endoscopy. Combined with the hands-on skills examination, this assessment tool is a key component for FES certification. 相似文献88.
89.
Spread of X inactivation on chromosome 15 is associated with a more severe phenotype in a girl with an unbalanced t(X; 15) translocation
下载免费PDF全文
![点击此处可从《American journal of medical genetics. Part A》网站下载免费的PDF全文](/ch/ext_images/free.gif)
90.